Infective Endocarditis: Review of All Cases in an Internal Medicine Department Over a 6 Year Period
DOI:
https://doi.org/10.24950/rspmi.569Keywords:
Risk Factors, Heart Failure, Endocarditis Bacterial/epidemiology, Endocarditis Bacterial/diagnosis, ComorbidityAbstract
Introduction: Despite an improvement in diagnostic and the- rapeutic procedures, infective endocarditis still carries a high mortality and morbidity that has been unchanged for the last 30 years. There has been a recent epidemiological shift trans- lated by an increase of prevalence in older patients, without the characteristic risk factors. This audit aims at analysing the characteristics of the patients admitted to the Internal Medi- cine wards due to infective endocarditis in a six year period. Methods: We selected all the cases coded as infective endo- carditis admitted to the Internal Medicine ward in the period from 01/01/2009 to 31/12/2014. Clinical data was obtained from the electronic medical records.
Results: We identified 40 cases (in 39 patients-32 men and seven women, medium age 62.3 years), which fulfilled the modified Duke’s criteria. Twenty-eight (70.0%) patients had native-valve endocarditis, five (12.5%) had prosthetic-valve involvement and two (5.0%) had vegetations elsewhere. Blood cultures were positive in 31 (77.5%) patients. Twenty-eight (70.0%) patients had complications, with valvular regurgitation in 15 (53.5%). Surgical intervention was required in 16 (40.0%) patients. Medium-time to diagnosis was 8.1 days. The avera- ge duration of in-hospital stay was 24.37 ± 31.68 days, with an in-hospital mortality of 17.5% (seven patients).
Conclusion: Our analysis reflects the reported epidemiologic shift with an increased incidence in older patients with a more severe presentation at admission. There was an increased in- cidence in an older population, which had more co-morbidi- ties and a more serious clinical presentation.
Downloads
References
Habib G, Hoen B, Tornos P, Thuny F, Prendergast B,Vilacosta I, et al. Guideli- nes on the prevention, diagnosis, and treatment of infective endocarditis. Eur Heart J. 2009; 30: 2369–413
Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet. 2012; 379: 965–75
Hoen B, Duval X. Infective endocarditis. N Engl J Med. 2013; 368:1425-33.
Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briançon S, et al. Chan- ging profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002; 288: 75–81
Cabell C, Jollis J, Peterson G, Corey G, Anderson DJ, Sexton DJ, et al. Chan-ging patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002; 162: 90–4
Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population- based profile of 1536 patients in Australia. Eur Heart J. 2010;31:1890-7
Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, et al. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010; 121:1005–13
Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC et al.- Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012; 366: 2466-73
Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta JP, Riberi A, et al.- The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011; 32: 2027- 33
Crawford MH, Durack DT. Clinical presentation of infective endocarditis. - Cardiol Clin. 2003; 21: 159-66
Botelho-Nevers E, Thuny F, Casalta JP, Richet H, Gouriet F, Collart F, et al. Dramatic reduction in infective endocarditis-related mortality with a manage- ment-based approach. Arch Intern Med. 2009; 169: 1290-8
Bayer A, Bolger A, Taubert K, Wilson W, Steckelberg J, Karchmer A, et al. Diagnosis and management of infective endocarditis and its complications. Circulation. 1998; 98: 2936-48
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000; 30: 633-8
Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg J. A sys- tematic review of population- based studies of infective endocarditis. Chest. 2007;132:1025-35
Sandre R, Shafran S. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis. 1996; 22: 276-86
Chu J, Wilkins G, Williams M. Review of 65 cases of infective endocarditis in Dunedin Public Hospital. NZ Med J. 2004; 20:117
Thuny F, Habib G. When should we operate on patients with acute infective endocarditis? Heart. 2010; 96: 892–97
Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Cli- nical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463-73
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Medicina Interna
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna